Pharmacogenetics in medico-legal context
Authors:
- A. SajantilaASA. Sajantila
- J.U. PaloJPJ.U. Palo
- I. OjanperäIOI. Ojanperä
- C. DavisCDC. Davis
- B. BudowleB. Budowle
- 1 December 2010
- journal article
- review article
- Published by Elsevier in Forensic Science International
- Vol. 203 (1-3) , 44-52
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Major epidemiological changes in sudden infant death syndrome: a 20-year population-based study in the UKThe Lancet, 2006
- The Metabolic Fate of Amitriptyline, Nortriptyline and Amitriptylinoxide in ManDrug Metabolism Reviews, 2004
- Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in SwedenPharmacogenetics, 2002
- Molecular Autopsy of Sudden Unexplained Death in the YoungAmerican Journal of Forensic Medicine & Pathology, 2001
- Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findingsCardiovascular Research, 2001
- Amitriptylinev.the rest: still the leading antidepressant after 40 years of randomised controlled trialsThe British Journal of Psychiatry, 2001
- Extension of a Pilot Study: Impact From the Cytochrome P450 2D6 Polymorphism on Outcome and Costs Associated With Severe Mental IllnessJournal of Clinical Psychopharmacology, 2000
- Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquineThe Lancet, 1993
- Extremely Rapid Hydroxylation of DebrisoquineTherapeutic Drug Monitoring, 1985
- Space-Time Relationships in Somesthetic LocalizationScience, 1956